药品损害赔偿基金制度研究  

Research on the system of the compensation fund for drug damage

作　　者：田东东 马辉[1] Tian Dongdong;Ma Hui(School of Medical Humanities,Capital Medical University,Beijing 100069,China)

机构地区：[1]首都医科大学医学人文学院,北京100069

出　　处：《中国卫生法制》2020年第6期11-14,53,共5页China Health Law

基　　金：北京市社会科学基金研究基地项目2017年度首都卫生管理与政策研究基地重点项目《因药致害患者救济制度研究》(17JDFXA008)。

摘　　要：通过对我国药品损害赔偿的现状分析,借鉴国外的药品损害赔偿制度,综合我国的基本国情和目前所具有的条件,建议国家充分利用我国的国情特点和制度优势,建立起以政府为主导,多方共同承担风险,多方共同监督管理的专门用于救济或者赔偿在药品损害事件中受害人的人身、财产损失的药品损害赔偿基金制度。Based on the analysis of the present situation of drug damage compensation in our country,drawing lessons from the foreign drug damage compensation system,and synthesizing the basic national conditions of our country and the various conditions at present,this paper suggested that the state should make full use of the characteristics and institutional advantages of our country’s national conditions and established a drug damage compensation fund system.The system should be a government-led,multi-party shared risk,multi-party joint supervision and management system,which was specially used for relief or compensation for the victims in drug damage incidents.

关 键 词：药害事件 损害赔偿 基金制度 

分 类 号：D902[政治法律—法学理论]